Quality control of flow cytometric immunophenotyping of haematological malignancies

Clinical and Laboratory Haematology

Volumn 21, Issue 3, 1999, Pages 155-160

  Gratama, J W ^a   Bolhuis, R L H ^a   Van 'T Veer, M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Flow cytometry; Immunophenotyping; Leukaemia; Lymphoproliferation; Quality control

Indexed keywords

CANCER DIAGNOSIS; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LABORATORY TEST; LEUKEMIA; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; VALIDATION PROCESS;

EID: 0032768827     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1999.00214.x     Document Type: Review

References (23)

1. Barnett D., Granger V. & Reilly J.T. (1994) The United Kingdom external quality assurance schemes (UK NEQAS) for leukaemia phenotyping. British Journal of Haematology 86, 83.
2. Borowitz M.J., Bray R., Gascoyne R. et al. (1997) US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry 30, 236-244.
3. Borowitz M.J., Guenther K.L., Shults K.E. & Stelzer G.T. (1993) Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. American Journal of Clinical Pathology 100, 534-540.
4. Braylan R.C., Borowitz M.J., Davis B.H., Stelzer G.T. & Stewart C.C. (1997a) US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry. Cytometry 30, 213.
5. Braylan R.C., Atwater S.K., Diamond L. et al. (1997b) US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting. Cytometry 30, 245-248.
6. Brisco M.J., Hughes E., Neoh S.H. et al. (1996) Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood 87, 5251-5256.
7. Davis B.H., Foucar K., Szczarkowski W. et al. (1997) US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Cytometry 30, 249-263.
8. Gratama J.W., Orfao A., Barnett D. et al. for the European Working Group on Clinical Cell Analysis (1998a) Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. Cytometry 34, 128-142.
9. Gratama J.W., D'hautcourt J.L., Mandy F. et al. for the European Working Group on Clinical Cell Analysis (1998b) Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. Cytometry 33, 166-178.
10. Jennings C.D. & Foon K.A. (1997) Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 90, 2863-2892.
11. Kishimoto T., Von Kikutani H., dem Borne A.E.G. et al. eds. (1997) Leukocyte Typing VI. Garland Press, London.
12. Kluin-Nelemans J.C., Van Wering E.R., van 't Veer M.B. et al. on behalf of the Dutch Cooperative Study Group on Immunophenotyping of Hematologic Malignancies (SIHON) (1996) Pitfalls in immunophenotyping of leukaemia and leukaemic lymphomas. British Journal of Haematology 95, 692-699.
13. Levey S. & Jennings E.R. (1950) The use of control charts in the clinical laboratory. Am J Clin Pathol 20: 1059-1066.
14. Marti G., Faguet G., Bertin P. et al. (1992). CD20 and CD5 expression in B-chronic lymphocytic leukemia. Annals of the New York Academy of Sciences 261, 480-483.
15. Riedy M.C., Muirhead K.A., Jensen C.P. & Stewart C.C. (1991) Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations. Cytometry 12, 133-139.
16. Rothe G. & Schmitz G. for the Working Group on Flow Cytometry and Image Analysis (1996) Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia 10, 877-895.
17. San Miguel J.F., Martínez A., Macedo A. et al. (1997) Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood 90, 2465-2470.
18. Schmid I., Krall W., Uittenbogaart C., Braun J. & Giorgi J. (1992) Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13, 204-208.
19. Schwartz A., Fernández-Repollet E., Vogt R. & Gratama J.W. (1996) Standardizing flow cytometry: construction of a standardized fluorescence calibration plot using matching spectral calibrators. Cytometry 26, 22-31.
20. Schwartz A., Marti G.E., Poon R., Gratama J.W. & Fernandez-Repollet E. (1998) Standardizing flow cytometry: a classification system of fluorescent standards used for flow cytometry. Cytometry 33, 106-114.
21. Stelzer G.T., Marti G., Hurley A., McCoy P. Jr, Lovett E.J. & Schwartz A. (1997) US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry 30, 214-230.
22. Stewart C.C., Behm F.G., Carey J.L. et al. (1997) US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry 30, 231-235.
23. Van 't Veer M.B., Kluin-Nelemans J.C., Van der Schoot C.E., Van Putten W.L.J., Adriaansen H.J. & Van Wering E.R. (1992) Quality assessment of immunological marker analysis and the immunological diagnosis in leukaemia and lymphoma: a multi-centre study. British Journal of Haematology 80, 458-465.